Cited by 776Atrial Fibrillation Management and OutcomesCardiac Health and Mental HealthHeart Failure Treatment and Management

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial

Abed, Hany S., Wittert, Gary A., Leong, Darryl P., Shirazi, Masoumeh G., Bahrami, Bobak, Middeldorp, Melissa E., Lorimer, Michelle F., Lau, Dennis H., Antic, Nicholas A., Brooks, Anthony G., Abhayaratna, Walter P., Kalman, Jonathan M., Sanders, Prashanthan·2013·JAMA

DOI 10.1001/jama.2013.280521

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Obesity is a risk factor for atrial fibrillation. Whether weight reduction and cardiometabolic risk factor management can reduce the burden of atrial fibrillation is not known. OBJECTIVE: To determine the effect of weight reduction and management of cardiometabolic risk factors on atrial fibrillation burden and cardiac structure. DESIGN, SETTING, AND PATIENTS: Single-center, partially blinded, randomized controlled study conducted between June 2010 and December 2011 in Adelaide, Australia, among overweight and obese ambulatory patients (N = 150) with symptomatic atrial fibrillation. Patients underwent a median of 15 months of follow-up. INTERVENTIONS: Patients were randomized to weight management (intervention) or general lifestyle advice (control). Both groups underwent intensive management of cardiometabolic risk factors. MAIN OUTCOMES AND MEASURES: The primary outcomes were Atrial Fibrillation Severity Scale scores: symptom burden and symptom severity. Scores were measured every 3 months from baseline to 15 months. Secondary outcomes performed at baseline and 12 months were total atrial fibrillation episodes and cumulative duration measured by 7-day Holter, echocardiographic left atrial area, and interventricular septal thickness. RESULTS: Of 248 patients screened, 150 were randomized (75 per group) and underwent follow-up. The intervention group showed a significantly greater reduction, compared with the control group, in weight (14.3 and 3.6 kg, respectively; P < .001) and in atrial fibrillation symptom burden scores (11.8 and 2.6 points, P < .001), symptom severity scores (8.4 and 1.7 points, P < .001), number of episodes (2.5 and no change, P = .01), and cumulative duration (692-minute decline and 419-minute increase, P = .002). Additionally, there was a reduction in interventricular septal thickness in the intervention and control groups (1.1 and 0.6 mm, P = .02) and left atrial area (3.5 and 1.9 cm2, P = .02). CONCLUSIONS AND RELEVANCE: In this study, weight reduction with intensive risk factor management resulted in a reduction in atrial fibrillation symptom burden and severity and in beneficial cardiac remodeling. These findings support therapy directed at weight and risk factors in the management of atrial fibrillation. TRIAL REGISTRATION: anzctr.org.au Identifier: ACTRN12610000497000.

Integrity signals

Registry

Crossref · 10.1001/jama.2013.280521

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research
(1999) · Sleep · doi:10.1093/sleep/22.5.667 · Cited by 5,147
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.
McNicholas, W. T., Strohl, K. P., White, D. P., Levy, P. A., Schmidt, W., Wheatley, J. R., Redline, S. S., Carley, D. W., Buysse, D. J., Young, T. B., et al. (1999) · PubMed · Cited by 3,665
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M. (2006) · Circulation · doi:10.1161/circulationaha.105.595140 · Cited by 2,564
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033

Show all 52 references

Sorted by citations

Items 101–200 of 775

Cardiac adipose tissue and atrial fibrillation: the perils of adiposity
Hatem, S. N., Redheuil, A. B., & Gandjbakhch, E. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw001 · Cited by 125
Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology
Harada, M., & Nattel, S. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.002 · Cited by 126
Management of Atrial Fibrillation in Patients 75 Years and Older
Volgman, A. S., Nair, G. G., Lyubarova, R., Merchant, F. M., Mason, P. K., Curtis, A. B., WENGER, N. K., Aggarwal, N. T., Kirkpatrick, J. N., & Benjamin, E. J. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.10.037 · Cited by 124
Clinical Benefit of Ablating Localized Sources for Human Atrial Fibrillation
Miller, J. M., Kalra, V., Das, M. K., Jain, R., Garlie, J. B., Brewster, J. A., & Dandamudi, G. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.079 · Cited by 120
Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association
Chyou, J. Y., Barkoudah, E., Dukes, J. W., Goldstein, L. B., Joglar, J. A., Lee, A. M., Lubitz, S. A., Marill, K. A., Sneed, K., Streur, M. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001133 · Cited by 127
Treatment of Atrial Fibrillation
Prystowsky, E. N., Padanilam, B. J., & Fogel, R. I. (2015) · JAMA · doi:10.1001/jama.2015.7505 · Cited by 117
Management of asymptomatic arrhythmias: a European Heart Rhythm Association (EHRA) consensus document, endorsed by the Heart Failure Association (HFA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin America Heart Rhythm Society (LAHRS)
Arnar, D. O., Mairesse, G. H., Boriani, G., Calkins, H. G., Chin, A., Coats, A. J. S., Deharo, J., Svendsen, J. H., Heidbüchel, H., Isa, R., et al. (2019) · EP Europace · doi:10.1093/europace/euz046 · Cited by 127
Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference
Kotecha, D., BREITHARDT, G. E., Camm, A. J., Lip, G. Y. H., Schotten, U., Ahlsson, A., Arnar, D. O., Atar, D., Auricchio, A., Bax, J. J., et al. (2018) · EP Europace · doi:10.1093/europace/eux318 · Cited by 117
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.046 · Cited by 113
Is Atrial Fibrillation a Preventable Disease?
Du, X., Dong, J., & Ma, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.020 · Cited by 117
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Linz, D., Andrade, J. G., Arbelo, E., Boriani, G., BREITHARDT, G. E., Camm, A. J., Caso, V., Nielsen, J. C., Melis, M. D., Potter, T. J. R. D., et al. (2024) · EP Europace · doi:10.1093/europace/euae070 · Cited by 124
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation
Elliott, A. D., Verdicchio, C. V., Mahajan, R., Middeldorp, M. E., Gallagher, C., Mishima, R. S., Hendriks, J. M. L., Pathak, R. K., Thomas, G., Lau, D. H., et al. (2023) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2022.12.002 · Cited by 116
Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy
Calenda, B. W., Fuster, V., Halperin, J. L., & Granger, C. B. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.106 · Cited by 117
Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications
Goudis, C. A., & Ketikoglou, D. G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.120 · Cited by 116
Lifestyle modifications for treatment of atrial fibrillation
Middeldorp, M. E., Ariyaratnam, J., Lau, D. H., & Sanders, P. (2019) · Heart · doi:10.1136/heartjnl-2019-315327 · Cited by 114
Impact of obesity on cardiac metabolism, fibrosis, and function
Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.005 · Cited by 109
Atrial Fibrillation, Cognitive Decline and Dementia
Alonso, Á., & Larriva, A. P. A.-D. (2016) · European Cardiology Review · doi:10.15420/ecr.2016:13:2 · Cited by 110
Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation
McCauley, M. D., Hong, L., Sridhar, A., Menon, A., Perike, S., Zhang, M., da Silva, I. B., Yan, J., Bonini, M. G., Ai, X., et al. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.008296 · Cited by 107
Stroke Prevention in Atrial Fibrillation
Katsanos, A. H., Kamel, H., Healey, J. S., & Hart, R. G. (2020) · Circulation · doi:10.1161/circulationaha.120.049768 · Cited by 108
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018
Brieger, D. B., Amerena, J. V., Attia, J., Bajorek, B. V., Chan, K. H., Connell, C., Freedman, B., Ferguson, C., Hall, T. L., Haqqani, H. M., et al. (2018) · The Medical Journal of Australia · doi:10.5694/mja18.00646 · Cited by 110
The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management
Pathak, R. K., Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.10.027 · Cited by 105
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Carotid Intima‐Media Thickness and Arterial Stiffness and the Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study, Multi‐Ethnic Study of Atherosclerosis (MESA), and the Rotterdam Study
Chen, L. Y., Leening, M. J. G., Norby, F. L., Roetker, N. S., Albert Hofman, D., Franco, O. H., Pan, W., Polak, J. F., Witteman, J. C. M., Kronmal, R. A., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002907 · Cited by 103
Lifestyle Medicine and the Management of Cardiovascular Disease
Doughty, K. N., Pilar, N. X. D., Audette, A., & Katz, D. L. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0925-z · Cited by 109
Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control])
Parkash, R., Wells, G. A., Sapp, J. L., Healey, J. S., Tardif, J.-C., Greiss, I., Rivard, L., Roux, J.-F., Gula, L., Nault, I., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026230 · Cited by 101
Mechanisms and Drug Development in Atrial Fibrillation
Calvo, D., Rama, D. F., & Jalife, J. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014183 · Cited by 99
Atrial fibrillation: comorbidities, lifestyle, and patient factors
Shantsila, E., Choi, E., Lane, D. A., Joung, B., & Lip, G. Y. H. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100784 · Cited by 108
Atrial Fibrillation and Obesity
Mahajan, R., Lau, D. H., Brooks, A. G., SHIPP, N. J., Wood, J. P. M., Manavis, J., Samuel, C. S., Patel, K. P., Finnie, J. W., Alasady, M., et al. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.11.015 · Cited by 99
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation
Chao, T., Joung, B., Takahashi, Y., Lim, T. W., Choi, E., Chan, Y., Guo, Y., Sriratanasathavorn, C., Oh, S., Okumura, K., et al. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12652 · Cited by 105
Quality indicators for the care and outcomes of adults with atrial fibrillation
Arbelo, E., (Chair), Aktaa, S., Bollmann, A., d’Ávila, A., Drossart, I., Dwight, J., Hills, M. T., Hindricks, G., Kusumoto, F. M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa253 · Cited by 100
Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial
Alonso, Á., Bahnson, J. L., Gaussoin, S. A., Bertoni, A. G., Johnson, K., Lewis, C. E., Vetter, M. L., Mantzoros, C. S., Jeffery, R. W., & Soliman, E. Z. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.07.026 · Cited by 99
Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta‐Analysis and Systematic Review
Zhu, W., Wan, R., Liu, F., Hu, J., Huang, L., Li, J., & Hong, K. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004006 · Cited by 97
Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9–10, 2013
Wagoner, D. R. V., Piccini, J. P., Albert, C. M., Anderson, M. E., Benjamin, E. J., Brundel, B. J. J. M., Califf, R. M., Calkins, H. G., Chen, P., Chiamvimonvat, N., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.11.011 · Cited by 95
Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study
Lee, H., Choi, E., Lee, S., Han, K., Rhee, T., Park, C., Lee, S., Choe, W.-S., Lim, W., Kang, S., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.103 · Cited by 97
The Interplay between Obstructive Sleep Apnea and Atrial Fibrillation
Marulanda-Londoño, E. T., & Chaturvedi, S. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00668 · Cited by 99
Atrial metabolism and tissue perfusion as determinants of electrical and structural remodelling in atrial fibrillation
Opačić, D., van Bragt, K. A., Nasrallah, H. M., Schotten, U., & Verheule, S. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw007 · Cited by 94
Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: The Fitbit heart study
Lubitz, S. A., Faranesh, A. Z., Atlas, S. J., McManus, D. D., Singer, D. E., Pagoto, S., Pantelopoulos, A., & Foulkes, A. S. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.04.003 · Cited by 94
Atrial fibrillation: stroke prevention
Chao, T., Potpara, T., & Lip, G. Y. H. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100797 · Cited by 103
Atrial Fibrillation Ablation
Nishida, K., Datino, T., Macle, L., & Nattel, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1172 · Cited by 92
The bidirectional association between atrial fibrillation and myocardial infarction
Frederiksen, T. C., Dahm, C. C., Preis, S. R., Lin, H., Trinquart, L., Benjamin, E. J., & Kornej, J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00857-3 · Cited by 95
Acquired risk factors and incident atrial fibrillation according to age and genetic predisposition
Wang, N., Yu, Y., Sun, Y. B., Zhang, H., Wang, Y., Chen, C., Tan, X. W., Wang, B., & Lu, Y. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad615 · Cited by 96
Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation
Wijesurendra, R. S., Liu, A., Eichhorn, C., Ariga, R., Levelt, E., Clarke, W. T., Rodgers, C. T., Karamitsos, T. D., Bashir, Y., Ginks, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022931 · Cited by 87
Demystifying rotors and their place in clinical translation of atrial fibrillation mechanisms
Nattel, S., Xiong, F., & Aguilar, M. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.37 · Cited by 89
Epidemiology of Atrial Fibrillation: The Australian and Asia-Pacific Perspective
Wong, C. X. J., Brown, A. D. H., Tse, H., Albert, C. M., Kalman, J. M., Marwick, T. H., Lau, D. H., & Sanders, P. (2017) · Heart Lung and Circulation · doi:10.1016/j.hlc.2017.05.120 · Cited by 89
World Heart Federation Roadmap on Atrial Fibrillation – A 2020 Update
Freedman, B., Hindricks, G., Banerjee, A., Baranchuk, A. M., Ching, C. K., Du, X., Fitzsimons, D., Healey, J. S., Ikeda, T., Lobban, T., et al. (2021) · Global Heart · doi:10.5334/gh.1023 · Cited by 95
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)
Balla, S. R., Cyr, D. D., Lokhnygina, Y. V., Becker, R. C., Berkowitz, S. D., BREITHARDT, G. E., Fox, K. A. A., Hacke, W., Halperin, J. L., Hankey, G. J., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.03.028 · Cited by 88
Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis
Anselmino, M., Matta, M., D'ascenzo, F., Pappone, C., Santinelli, V., Bunch, T. J., Neumann, T., Schilling, R. J., Hunter, R. J., Noelker, G., et al. (2015) · Europace · doi:10.1093/europace/euv214 · Cited by 88
Cost-Effectiveness and Clinical Effectiveness of the Risk Factor Management Clinic in Atrial Fibrillation
Pathak, R. K., Evans, M., Middeldorp, M. E., Mahajan, R., Mehta, A. B., Meredith, M., Twomey, D. J., Wong, C. X. J., Hendriks, J., Abhayaratna, W. P., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.12.015 · Cited by 87
Cardioversion of atrial fibrillation in obese patients: Results from the Cardioversion‐BMI randomized controlled trial
Voskoboinik, A., Moskovitch, J. T., Plunkett, G., Bloom, J. E., Wong, G. R., Nalliah, C. J., Prabhu, S., Sugumar, H., Parameswaran, R., McLellan, A. J. A., et al. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13786 · Cited by 81
Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation
Carnagarin, R., Kiuchi, M. G., Ho, J. K., Matthews, V. B., & Schlaich, M. P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.01058 · Cited by 81
Sleep apnoea and heart failure
Levy, P. A., Naughton, M. T., Tamisier, R., Cowie, M., & Bradley, T. D. (2021) · European Respiratory Journal · doi:10.1183/13993003.01640-2021 · Cited by 82
Guía ESC 2021 sobre la prevención de la enfermedad cardiovascular en la práctica clínica
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Bénétos, A., Biffi, A., Boavida, J. M., Capodanno, D., et al. (2022) · Revista Española de Cardiología · doi:10.1016/j.recesp.2021.10.016 · Cited by 89
Prevention and Treatment of Atrial Fibrillation via Risk Factor Modification
O’Keefe, E. L., Sturgess, J. E., O’Keefe, J. H., Gupta, S. K., & Lavie, C. J. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.042 · Cited by 86
Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea
Nalliah, C. J., Wong, G. R., Lee, G., Voskoboinik, A., Kee, K., Goldin, J., Watts, T. W., Linz, D., Parameswaran, R., Sugumar, H., et al. (2022) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2022.04.015 · Cited by 76
Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications
Linz, D., Linz, B. M., Hohl, M., & Böhm, M. (2015) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.03.003 · Cited by 76
Structural and Functional Remodeling of the Left Atrium: Clinical and Therapeutic Implications for Atrial Fibrillation.
Pathak, R. K., Lau, D. H., Mahajan, R., & Sanders, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.986 · Cited by 78
Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation
Gutiérrez, A., & Wagoner, D. R. V. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000313 · Cited by 74
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients
Sivasambu, B., Balouch, M. A., Zghaib, T., Bajwa, R. J., Chrispin, J., Berger, R. D., Ashikaga, H., Nazarian, S., Marine, J. E., Calkins, H. G., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13388 · Cited by 74
2021 ISHNE/HRS/EHRA/APHRS Expert Collaborative Statement on mHealth in Arrhythmia Management: Digital Medical Tools for Heart Rhythm Professionals: From the International Society for Holter and Noninvasive Electrocardiology/Heart Rhythm Society/European Heart Rhythm Association/Asia-Pacific Heart Rhythm Society
Varma, N., Cygankiewicz, I., Turakhia, M. P., Heidbuchel, H., Hu, Y.-F., Chen, L. Y., Couderc, J.-P., Cronin, E. M., Estep, J. D., Grieten, L., et al. (2021) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009204 · Cited by 74
Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation
Ruff, C. T., Giugliano, R. P., D, E. B. M., Murphy, S. A., Brown, K. S., Jarolı́m, P., Mercuri, M. F., Antman, E. M., & Morrow, D. A. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3311 · Cited by 71
Atrial fibrillation and gastroesophageal reflux disease: the cardiogastric interaction
Linz, D., Hohl, M., Vollmar, J., Ukena, C., Mahfoud, F., & Böhm, M. (2016) · EP Europace · doi:10.1093/europace/euw092 · Cited by 72
Epicardial adipose tissue as a mediator of cardiac arrhythmias
Patel, K. H. K., Hwang, T., Liebers, C. S., & Ng, F. S. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00565.2021 · Cited by 77
Subclinical Myocardial Impairment in Metabolic Diseases
Kosmala, W., Sanders, P., & Marwick, T. H. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.04.001 · Cited by 71
Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference
Fabritz, L., Crijns, H. J. G. M., Guasch, E., Goette, A., Häusler, K. G., Kotecha, D., Lewalter, T., Meyer, C. G., Potpara, T., Rienstra, M., et al. (2020) · EP Europace · doi:10.1093/europace/euaa279 · Cited by 70
Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance
Gawalko, M. M., Saljic, A., Li, N., Abu-Taha, I., Jespersen, T., Linz, D., Nattel, S., Heijman, J., Fender, A. C., & Dobrev, D. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac093 · Cited by 68
Challenges in Cardiovascular Evaluation and Management of Obese Patients
Bianchettin, R. G., Lavie, C. J., & López-Jiménez, F. A. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.11.031 · Cited by 73
Pericardial fat and atrial fibrillation: Epidemiology, mechanisms and interventions
Rawahi, M. N. A., Proietti, R., & Thanassoulis, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.129 · Cited by 67
An update on atrial fibrillation in 2014: From pathophysiology to treatment
Ferrari, R., Bertini, M., Blomström‐Lundqvist, C., Dobrev, D., Kirchhof, P. F., Pappone, C., Ravens, U., Tamargo, J. L., Tavazzi, L., & Vicedomini, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.089 · Cited by 67
Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it
Nattel, S., Sager, P. T., Hüser, J., Heijman, J., & Dobrev, D. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab093 · Cited by 64
Impact of weight loss on ablation outcome in obese patients with longstanding persistent atrial fibrillation
Mohanty, S., Mohanty, P. K., Natale, V. N., Trivedi, C. G., Gianni, C., Burkhardt, J. D., Sánchez, J., Horton, R., Gallinghouse, G. J., Hongo, R. H., et al. (2017) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13394 · Cited by 66
Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction in Patients With Nonalcoholic Fatty Liver Disease
Packer, M. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.09.002 · Cited by 63
Vagal atrial fibrillation: What is it and should we treat it?
Carpenter, A., Frontera, A., Bond, R., Duncan, E., & Thomas, G. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.08.108 · Cited by 65
Exercise and Atrial Fibrillation: Prevention or Causation?
Elliott, A. D., Linz, D., Verdicchio, C. V., & Sanders, P. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.04.296 · Cited by 65
Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction
Packer, M. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.09.002 · Cited by 65
Inflammation, Inflammasome Activation, and Atrial Fibrillation
Wagoner, D. R. V., & Chung, M. K. (2018) · Circulation · doi:10.1161/circulationaha.118.036143 · Cited by 65
Pericardial fat volume is associated with clinical recurrence after catheter ablation for persistent atrial fibrillation, but not paroxysmal atrial fibrillation: An analysis of over 600-patients
Kim, T., Park, J., Park, J.-K., Uhm, J., Joung, B., Lee, M., & Pak, H. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.008 · Cited by 64
Cardiovascular exercise and burden of arrhythmia in patients with atrial fibrillation - A randomized controlled trial
Skielboe, A. K., Bandholm, T., Hakmann, S., Mourier, M., Kallemose, T., & Dixen, U. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170060 · Cited by 69
Obesity and atrial fibrillation: making inroads through fat
Javed, S., Gupta, D., & Lip, G. Y. H. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa013 · Cited by 65
The role of exercise in atrial fibrillation prevention and promotion: Finding optimal ranges for health
Elliott, A. D., Maatman, B. T., Emery, M. S., & Sanders, P. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.07.001 · Cited by 63
Do Most Patients with Obesity or Type 2 Diabetes, and Atrial Fibrillation, Also have Undiagnosed Heart Failure? A Critical Conceptual Framework for Understanding Mechanisms and Improving Diagnosis and Treatment
Packer, M. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1646 · Cited by 67
Obesity and cardiovascular risk
Kotsis, V., Tsioufis, K. P., Antza, C., Seravalle, G., Coca, A., Sierra, C., Lurbe, E., Stabouli, S., Jelaković, B., Redón, J., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001731 · Cited by 66
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations
López‐Fernández, T., Martín‐Garcia, A., Rabadán, I. R., Mitroi, C. D., Mazón‐Ramos, P., Díez‐Villanueva, P., Escobar, C., Alonso‐Martín, C., Salinas, G. L. A., Arenas, M., et al. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.019 · Cited by 62
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective
Piccini, J. P., Allred, J. D., Bunch, T. J., Deering, T. F., Biase, L. D., Hussein, A. A., Lewis, W. R., Mittal, S., Natale, A., Osorio, J., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.04.033 · Cited by 63
Body mass index and the risk of new-onset atrial fibrillation in middle-aged adults
Berkovitch, A., Kivity, S., Klempfner, R., Segev, S., Milwidsky, A., Erez, A., Sabbag, A., Goldenberg, I., Sidi, Y., & Maor, E. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.11.016 · Cited by 62
Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death
Homan, E. A., Reyes, M. V., Hickey, K. T., & Morrow, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2018.01847 · Cited by 63
Lifestyle Modification in the Prevention and Treatment of Atrial Fibrillation
Menezes, A. R., Lavie, C. J., Schutter, A. D., Milani, R. V., O’Keefe, J. H., DiNicolantonio, J. J., Morin, D. P., & ABI‐SAMRA, F. M. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.001 · Cited by 58
The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation
Desteghe, L., Hendriks, J., McEvoy, R. D., Chai‐Coetzer, C. L., Dendale, P., Sanders, P., Heidbüchel, H., & Linz, D. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1248-9 · Cited by 59
Association of Body Mass Index With Care and Outcomes in Patients With Atrial Fibrillation
Pandey, A., Gersh, B. J., McGuire, D. K., Shrader, P. J., Thomas, L. E., Kowey, P. R., Mahaffey, K. W., Hylek, E. M., Sun, S., Burton, P. B. J., et al. (2015) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2015.12.001 · Cited by 59
Association of left atrial epicardial adipose tissue with electrogram bipolar voltage and fractionation: Electrophysiologic substrates for atrial fibrillation
Zghaib, T., İpek, E. G., Zahid, S., Balouch, M. A., Misra, S. K., Ashikaga, H., Berger, R. D., Marine, J. E., SPRAGG, D. D., Zimmerman, S. L., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.08.030 · Cited by 59
Integrated specialized atrial fibrillation clinics reduce all-cause mortality: post hoc analysis of a randomized clinical trial
Hendriks, J., Tieleman, R. G., Vrijhoef, H. J., Wijtvliet, P., Gallagher, C., Prins, M. H., Sanders, P., & Crijns, H. J. G. M. (2019) · EP Europace · doi:10.1093/europace/euz209 · Cited by 58
The Impact of Diet and Lifestyle on Atrial Fibrillation
Nalliah, C. J., Sanders, P., & Kalman, J. M. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1082-8 · Cited by 63
Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes
Gunawardene, M., & Willems, S. (2021) · EP Europace · doi:10.1093/europace/euab257 · Cited by 56
Atrial Fibrillation Detection and Management in Hypertension
Gawalko, M. M., & Linz, D. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19459 · Cited by 64
Atrial Fibrillation in Athletes
Estes, N. A. M., & Madias, C. (2017) · JACC: Clinical Electrophysiology · doi:10.1016/j.jacep.2017.03.019 · Cited by 56
Risk factor management and atrial fibrillation
Hendriks, J., Gallagher, C., Middeldorp, M. E., Lau, D. H., & Sanders, P. (2020) · EP Europace · doi:10.1093/europace/euaa346 · Cited by 56
Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults
Foy, A., Mandrola, J. M., Liu, G., & Naccarelli, G. V. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.019 · Cited by 56
Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis
Hartmann-Boyce, J., Theodoulou, A., Oke, J. L., Butler, A. R., Bastounis, A., Dunnigan, A., Byadya, R., Cobiac, L. J., Scarborough, P., Hobbs, F. D. R., et al. (2023) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.122.009348 · Cited by 53
Interaction of obesity and atrial fibrillation: an overview of pathophysiology and clinical management
Pouwels, S., Topal, B., Knook, M. T. T., Çelik, A., Sundbom, M., Ribeiro, R. J. D. S., Parmar, C. D., & Ugale, S. M. (2019) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2019.1581064 · Cited by 54
Treatment of OSA and its Impact on Cardiovascular Disease, Part 2
Javaheri, S., Javaheri, S., Gozal, D., Campos‐Rodríguez, F., Martínez‐García, M. Á., Mokhlesi, B., Mehra, R., McNicholas, W. T., Somers, V. K., Zee, P. C., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.024 · Cited by 51
Body Mass Index Variability and Long-term Risk of New-Onset Atrial Fibrillation in the General Population: A Korean Nationwide Cohort Study
Lim, Y.-M., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.10.019 · Cited by 54

Authors: Abed, H. S., Wittert, G. A., Leong, D. P., Shirazi, M. G., Bahrami, B., Middeldorp, M. E., Lorimer, M. F., Lau, D. H., Antic, N. A., Brooks, A. G., Abhayaratna, W. P., Kalman, J. M., & Sanders, P.
Affiliations: Royal Adelaide Hospital (AU)
The University of Adelaide (AU)
Repatriation General Hospital (AU)
Australian National University (AU)
The Royal Melbourne Hospital (AU)
ORCID: Wittert, Gary A.
Leong, Darryl P.
Bahrami, Bobak
Middeldorp, Melissa E.
Lorimer, Michelle F.
Lau, Dennis H.
Abhayaratna, Walter P.
Kalman, Jonathan M.
Sanders, Prashanthan
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2013-11-20
Volume: 310
Issue: 19
Pages: 2050
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2013.280521
OpenAlex: W1963940525
Cited by: 776
References: 52
Citations by year: 2026: 51 · 2025: 64 · 2024: 69 · 2023: 53 · 2022: 56 · 2021: 76 · 2020: 50 · 2019: 70 · 2018: 52 · 2017: 81 · 2016: 63 · 2015: 51 · 2014: 35 · 2013: 4
FWCI: 34.64
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Flinders Academic Commons (Flinders University) (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Flinders Academic Commons (Flinders University) (submittedVersion)
ANU Open Research (Australian National University) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: weight loss, obesity, cardiometabolic risk factors, symptom burden, symptom severity, cardiac remodeling, left atrial area, interventricular septum thickness, lifestyle intervention, overweight patients, Holter monitoring, cardiac structure, risk factor control, weight management, lifestyle advice
MeSH terms: Aged, Atrial Fibrillation, Diet, Reducing, Echocardiography, Fish Oils, Heart Atria, Humans, Life Style, Male, Middle Aged, Obesity, Risk Factors, Severity of Illness Index, Weight Loss, Treatment Outcome, Overweight

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Weight Reduction and Cardiometabolic Risk Factor Management on Symptom Burden and Severity in Patients With Atrial Fibrillation: A Randomized Clinical Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks